Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 296

Results For "treatment"

3726 News Found

Evusheld significantly protected against symptomatic Covid-19 for at least six months
Biotech | April 21, 2022

Evusheld significantly protected against symptomatic Covid-19 for at least six months

Pre-exposure prevention trial reduced risk of symptomatic Covid-19, with no severe disease or Covid-19-related deaths in the Evusheld group


Saraq Hepatitis C kit receives CDSCO nod
Drug Approval | April 21, 2022

Saraq Hepatitis C kit receives CDSCO nod

The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth


Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses
Drug Approval | April 21, 2022

Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses

Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses


CK Birla Hospital performs highest number of VABB surgeries in a year
Hospitals | April 21, 2022

CK Birla Hospital performs highest number of VABB surgeries in a year

Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress


Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug
Drug Approval | April 20, 2022

Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug

Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA


BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer
Drug Approval | April 20, 2022

BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer

The launch is yet another first of its kind innovation in India


Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19
News | April 20, 2022

Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19

Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19


Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon
Biotech | April 19, 2022

Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon

By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)


AI driven Israeli company Embryonics ties-up with Jaslok Hospital
Digitisation | April 19, 2022

AI driven Israeli company Embryonics ties-up with Jaslok Hospital

The data driven fertility company helps increase the success rate of fertility treatments


Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India
News | April 19, 2022

Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India

Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer